Dr. Reddy's Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1500mg/100mL Due to Mislabeling

0
17
FDA Suspends Routine Food Inspections Due to the COVID-19 Pandemic Outbreak
FDA Suspends Routine Food Inspections Due to the COVID-19 Pandemic Outbreak



Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it’s wholly owned subsidiary, Dr Reddy’s Laboratories, Inc is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram in 0. 54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose extract bags to the hospital amount in U.S.A.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here